Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Thrombosis and Haemostasis
|
January 25, 2008
Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial
Uwe Zeymer, Anselm Gitt, Claus Jünger, et al.
Zeitschrift Fur Kardiologie
|
August 12, 1999
[Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study. Maximal Individual Optimized Therapy for Acute Myocardial Infarct]
R Zahn, R Schiele, S Schneider, et al.
Heart (British Cardiac Society)
|
September 22, 1999
Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group
R Zahn, R Schiele, K Seidl, et al.
The Journal of Invasive Cardiology
|
April 4, 2000
Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities?
R Zahn, R Schiele, K Seidl, et al.
Klinische Wochenschrift
|
January 1, 1988
[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]
K L Neuhaus, U Tebbe, M Gottwik, et al.
Zeitschrift Fur Kardiologie
|
February 22, 2003
Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats
A Drögemüller, K Seidl, R Schiele, et al.
The American Journal of Cardiology
|
December 5, 1997
Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze
R Zahn, J Rustige, A Koch, et al.
Clinical Cardiology
|
March 20, 1999
Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group
R Zahn, S Schuster, R Schiele, et al.
The American Journal of Cardiology
|
January 4, 2001
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
Journal of the American College of Cardiology
|
September 1, 1988
Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)
K L Neuhaus, U Tebbe, M Gottwik, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Thrombosis and Haemostasis
|
January 25, 2008
Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial
Uwe Zeymer, Anselm Gitt, Claus Jünger, et al.
Zeitschrift Fur Kardiologie
|
August 12, 1999
[Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study. Maximal Individual Optimized Therapy for Acute Myocardial Infarct]
R Zahn, R Schiele, S Schneider, et al.
Heart (British Cardiac Society)
|
September 22, 1999
Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group
R Zahn, R Schiele, K Seidl, et al.
The Journal of Invasive Cardiology
|
April 4, 2000
Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities?
R Zahn, R Schiele, K Seidl, et al.
Klinische Wochenschrift
|
January 1, 1988
[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]
K L Neuhaus, U Tebbe, M Gottwik, et al.
Zeitschrift Fur Kardiologie
|
February 22, 2003
Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats
A Drögemüller, K Seidl, R Schiele, et al.
The American Journal of Cardiology
|
December 5, 1997
Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze
R Zahn, J Rustige, A Koch, et al.
Clinical Cardiology
|
March 20, 1999
Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group
R Zahn, S Schuster, R Schiele, et al.
The American Journal of Cardiology
|
January 4, 2001
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry
R Zahn, R Schiele, S Schneider, et al.
Journal of the American College of Cardiology
|
September 1, 1988
Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)
K L Neuhaus, U Tebbe, M Gottwik, et al.
Page
of 8